POLYMORPHISM OF THE MDR1 GENE IN PATIENTS WITH CHRONIC GASTRITIS

Authors

  • Ochilov Alisher Kamilovich Author

Keywords:

Genotyping, polymorphism, chronic gastritis, proton pump inhibitors, pharmacotherapy, polymorphic markers

Abstract

The article discusses the results of genotyping patients to improve the pharmacotherapy of acid-dependent diseases of the digestive system by the CYP2C19 gene, which provides the pharmacokinetics of drugs from the proton pump inhibitor group contributed to improving the effectiveness, safety and personalization of pharmacotherapy, which serves to improve the quality of life of patients. 

References

1. Alexander J. Kvist, Kajsa P. Kanebratt, Anna Walentinsson, Henrik Palmgren,

Matthew O'Hara, Anders Bjerkbom, Linda C. Andersson, Marie Ahlqvist,

Tommy B. Andersson, Critical differences in drug metabolic properties of

human hepatic cellular models, including primary human hepatocytes, stem cell

derived

hepatocytes,

and

hepatoma

cell

lines,

Biochemical

Pharmacology,Volume 155, 2018, Pages 124-140,ISSN 0006-2952,

https://doi.org/10.1016/j.bcp.2018.06.026.

2. Applications for pharmacogenomics in pharmacy practice: A scoping review.

Research in Social and Administrative Pharmacy. Vol. 18, Issue 7, 2022, P.

3094-3118,ISSN 1551-7411.

3. Bernhard Otto Behm, Simone Claudi-Behm, 2 - Gendiagnostik, Editor(s): Birgid

Neumeister, Bernhard Otto Behm, In Klinikleitfaden, Klinikleitfaden

Labordiagnostik (Sechste Ausgabe), Urban & Fischer, 2018, Pages 25-31, ISBN

9783437222351,

https://doi.org/10.1016/B978-3-437-22235-1.00002-4.

4. Demisew G. Factors Associatedwith Gastric Disease Among Students of

Hawassa University: The Caseof College of Agriculture Students.American

Journal of Theoretical and Applied Statistics. 2018; 7 (6); 207-14.

http://doi:10.11648/j.ajtas.20180706.12

5. Musaeva D. M., Ochilova G. S. Surunkali uzoq davom etadigan turlar MDR-1

allel varianti ko ' rish qiymati// Xalq fan-amaliyoti onlayn materialari//XXI asr

tibbiyot intizomi fanning dolzarb muommolari. Toshkent. Uzbekiston. – 2019. -

B. 258-259.

6. Musaeva D. M., Ochilov A. K. farmakoterapiyani individuallashtirish uchun

cyp2c19 genining xususiyatlari// tibbiyotda yangi kun. – 2020. - №1 (29). - P.

65-68.

7. Ochilova G. S., Musaeva D. M.Mdr1 gen polimorfizmining surunkali gastritni

davolash samaradorligiga ta'siri// tibbiyotda yangi kun. - 2020. - T. 1. - №29. -

P. 309-312.

8. Ochilova G. S. glikoprotein-P ning dorivor moddalar tashuvchisining oqsili

sifatida xususiyatlari / / tibbiyotda yangi kun. – 2020. - T. 2. - №30/2. - P. 60

53.

9. Ochilov A. K. gastroenterologiya uchun sitokrom P450 ning ahamiyati / /

tibbiyotda yangi kun. – 2020. - №2 (30/2). - 57-59 betlar

10. Fricke-Galindo,

H.

Jung-Cook,

A. LLerena, M. Leіpez-Leіpez,

Farmacogenetica de reacciones adversas a fermacos antiepilepticos, Neurologia,

Volume 33, Issue 3, 2018, Pages 165-176, ISSN 0213-4853,

https://doi.org/10.1016/j.nrl.2015.03.005.

11. Joseph F. Goldberg, Charles B. Nemeroff, Chapter 9 - Pharmacogenomics and

antidepressants: efficacy and adverse drug reactions, Editor(s): Evangelia Eirini

Tsermpini, Martin Alda, George P. Patrinos, In Translational and Applied

Genomics, Psychiatric Genomics, Academic Press, 2022, Pages 189-202, ISBN

9780128196021,

https://doi.org/10.1016/B978-0-12-819602-1.00011-5.

12. Klotz U, Schwab M, Treiber G. CYP2C19 polymorphism and proton pump

inhibitors. Basic Clin. Pharmacol. Toxicol., 2004. 95: 2–8.

13. 87. Livak, Kenneth J. and Thomas D. Schmittgen. “Analysis of relative gene

expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))

Method.” METHODS 25 4 (2001): 402-8

14. Ochilova G. S. farmakoterapiyada shaxsiylashtirish uchun mdr1 genining o'ziga

xos xususiyati / / xalqaro ishtirokdagi III Butunrossiya ilmiy-amaliy

konferentsiyasining tezislari to'plami / / Farmakoterapiya xavfsizligi: NOLI

NOCERE!. Qozon. Rossiya. - 2020. - P. 161-162.

15. Ochilov A. K. surunkali gastritni davolash samaradorligiga cyp2c19 genining

ta'siri / / xalqaro ishtirokdagi III Butunrossiya ilmiy-amaliy konferentsiyasining

tezislari to'plami / / Farmakoterapiya xavfsizligi: NOLI NOCERE! Qozon.

Rossiya. – 2020. - P. 160-161.

Published

2024-12-24

How to Cite

Ochilov Alisher Kamilovich. (2024). POLYMORPHISM OF THE MDR1 GENE IN PATIENTS WITH CHRONIC GASTRITIS. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 60(1), 289-299. https://scientific-jl.org/obr/article/view/7071